NEXENTIS TECHNOLOGIES INC. Current Assets
NEXENTIS TECHNOLOGIES INC. (NXTS) had Current Assets of $10.39 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $10.39M.
- 2026-03-31: Assets, Current $8.22M.
- 2025-12-31: Assets, Current $6.01M.
- 2025-09-30: Assets, Current $8.66M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.39M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $8.22M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $6.01M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.66M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.02M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.33M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.45M 10-K · filed 2026-03-31 | $3.40M 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.37M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $5.46M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $4.42M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $5.47M 10-K · filed 2025-03-31 | $5.47M 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.85M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.96M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.28M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $6.27M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $7.51M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.00M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.20M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $7.23M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $8.51M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $10.10M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $701.58K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $495.17K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $394.30K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $135.50K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $254.46K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $424.61K 10-K · filed 2021-03-29 | |
| 2018-12-31 | $676.68K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |